Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a -11.521% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a) COc1ccc(-n2cnc3cc(NCc4ccco4)ccc32)cc1
b) CN1CCN(c2nc(C(N)=O)cc(-c3ccccc3)n2)CC1
c) CCn1c(C2CC(=O)N(c3ccc(C)c(C)c3)C2)nc2ccccc21
Answer: c. CCn1c(C2CC(=O)N(c3ccc(C)c(C)c3)C2)nc2ccccc21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCn1c(C2CC(=O)N(c3ccc(C)c(C)c3)C2)nc2ccccc21
CCn1c(C2CC(=O)N(c3ccc(C)c(C)c3)C2)nc2ccccc21
1-(3,4-dimethylphenyl)-4-(1-ethylbenzimidazol-2-yl)pyrrolidin-2-one